SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.98-1.0%11:37 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pseudo Biologist who wrote (5421)1/29/1998 8:07:00 PM
From: aknahow  Read Replies (2) of 17367
 
Yes, makes points that while not overly exciting or dramatic are relevant to ivesting in high tech. Even if one knows in advance that R & D must be writen off immediatly but if you buy a plant the cost is amortized. The more a co spends on R & d ina given yr. the grter the negtive impact on earnings. New point? No. But easy to forget when these stocks get hammered for a few cents shortfall on the whisper earnings number. So evn though I knew tis I have not usually made any adjustments for difference in R & D spending before reacting to the earnings number or acting on it by eciding to buy as a stock gets crushed.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext